269 related articles for article (PubMed ID: 16621991)
1. Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
Antony PA; Paulos CM; Ahmadzadeh M; Akpinarli A; Palmer DC; Sato N; Kaiser A; Hinrichs CS; Klebanoff CA; Tagaya Y; Restifo NP
J Immunol; 2006 May; 176(9):5255-66. PubMed ID: 16621991
[TBL] [Abstract][Full Text] [Related]
2. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
Bayer AL; Yu A; Malek TR
J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.
Antony PA; Piccirillo CA; Akpinarli A; Finkelstein SE; Speiss PJ; Surman DR; Palmer DC; Chan CC; Klebanoff CA; Overwijk WW; Rosenberg SA; Restifo NP
J Immunol; 2005 Mar; 174(5):2591-601. PubMed ID: 15728465
[TBL] [Abstract][Full Text] [Related]
4. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
[TBL] [Abstract][Full Text] [Related]
5. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
Stephens LA; Mottet C; Mason D; Powrie F
Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
[TBL] [Abstract][Full Text] [Related]
6. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
Setoguchi R; Hori S; Takahashi T; Sakaguchi S
J Exp Med; 2005 Mar; 201(5):723-35. PubMed ID: 15753206
[TBL] [Abstract][Full Text] [Related]
7. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
8. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.
Marie JC; Letterio JJ; Gavin M; Rudensky AY
J Exp Med; 2005 Apr; 201(7):1061-7. PubMed ID: 15809351
[TBL] [Abstract][Full Text] [Related]
11. High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
Hernandez R; LaPorte KM; Hsiung S; Santos Savio A; Malek TR
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34475132
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.
Thornton AM
Front Biosci; 2006 Jan; 11():921-7. PubMed ID: 16146782
[TBL] [Abstract][Full Text] [Related]
13. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
15. IL-2 family of cytokines in T regulatory cell development and homeostasis.
Malek TR; Yu A; Zhu L; Matsutani T; Adeegbe D; Bayer AL
J Clin Immunol; 2008 Nov; 28(6):635-9. PubMed ID: 18726679
[TBL] [Abstract][Full Text] [Related]
16. IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus.
Hemmers S; Schizas M; Azizi E; Dikiy S; Zhong Y; Feng Y; Altan-Bonnet G; Rudensky AY
J Exp Med; 2019 Nov; 216(11):2466-2478. PubMed ID: 31434685
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
[TBL] [Abstract][Full Text] [Related]
18. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
Zhang H; Chua KS; Guimond M; Kapoor V; Brown MV; Fleisher TA; Long LM; Bernstein D; Hill BJ; Douek DC; Berzofsky JA; Carter CS; Read EJ; Helman LJ; Mackall CL
Nat Med; 2005 Nov; 11(11):1238-43. PubMed ID: 16227988
[TBL] [Abstract][Full Text] [Related]
19. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
20. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
